Skip to main content
. 2023 Dec 23;34(2):318–329. doi: 10.1016/j.zemedi.2023.12.001

Table 1.

Demographic information of the subject data used in this study.

MS patients HC
No. of subjects 327 84
Age (yrs.) 38.75 (SD: 10.08) 36.94 (SD: 12.55)
female/male/n.a. 193/111/23 44/40
EDSS 1.0 (IQR: 2.5)

EDSS of 32 subjects were not available; n.a. = not available.